Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2022 | The impact of bariatric surgery on the outcomes of patients with CML treated with TKIs

Fadi Haddad • 24 Jun 2022
EHA 2022
Chronic Myeloid Leukemia Leukemia

Fadi Haddad, MD, MD Anderson Cancer Center, Houston, TX, discusses the results of a study investigating the impact of bariatric surgery on the outcomes of patients with chronic myeloid leukemia (CML) treated with tyrosine kinase inhibitors (TKIs). Overall, the study found that patients who had bariatric surgery had a worse failure-free survival (FFS), as well as a worse overall survival (OS), and took a longer time to achieve a complete cytogenetic remission (CCyR) and major molecular response (MMR) than patients who had not undergone a bariatric surgery. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

More from Fadi Haddad

Beyond the label: optimal dosing strategies for CML in community practice
0:51
Beyond the label: optimal dosing strategies for CML in community practice
Fadi Haddad • 10 Sep 2026
Adjusting treatment to improve tolerability in patients with CML
2:02
Adjusting treatment to improve tolerability in patients with CML
Fadi Haddad • 10 Sep 2026
Phase I ENABLE trial of ELVN-001, a selective ATP-competitive inhibitor of BCR::ABL1, in R/R CML
3:13
Phase I ENABLE trial of ELVN-001, a selective ATP-competitive inhibitor of BCR::ABL1, in R/R CML
Fadi Haddad • 10 Sep 2026
Predictive factors for successful treatment-free remission in CML
2:08
Predictive factors for successful treatment-free remission in CML
Fadi Haddad • 7 Dec 2025

Related Videos

Unmet needs in CLL genomics: heterogeneity and clinical impact
1:11
Unmet needs in CLL genomics: heterogeneity and clinical impact
Elias Campo • 16 Oct 2026
Insights into key topics most likely to impact day-to-day CLL management
1:40
Insights into key topics most likely to impact day-to-day CLL management
Alessandra Ferrajoli • 16 Oct 2026
Translating current CLL evidence into national guidelines: which gaps remain?
3:33
Translating current CLL evidence into national guidelines: which gaps remain?
Mary Ann Anderson • 16 Oct 2026
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
2:40
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
Philip Thompson • 22 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals